SCHEMBL12469656

SCHEMBL12469656

FC(c1ccccc1)(c1ccccc1)N1CCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.59
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.42
CYP2D6 P10635 5/20 0.42
KCNH2 Q12809 4/20 0.42
CHRM2 P08172 3/20 0.42
CHRM1 P11229 3/20 0.42
LMNA P02545 3/20 0.42
HTR1A P08908 2/20 0.42
OPRM1 P35372 2/20 0.42
KDM4E B2RXH2 3/20 0.40
CHRM4 P08173 2/20 0.40
CHRM5 P08912 2/20 0.40
CHRM3 P20309 2/20 0.40
DRD2 P14416 1/20 0.40
DRD1 P21728 1/20 0.40
HTR2A P28223 1/20 0.40
DRD3 P35462 1/20 0.40
SCN1A P35498 1/20 0.40
SCN2A Q99250 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1337702 0.83 CYP2B6 (0.59) CYP2B6ALDH1A1TSHRCYP2D6KCNH2
SCHEMBL1338545 0.80 CYP2B6 (0.55) CYP2B6ALDH1A1TSHRCYP2D6KCNH2
SCHEMBL7317038 0.79 SIGMAR1 (0.46) ALDH1A1TSHRCYP2D6CHRM2CHRM1
SCHEMBL19296941 0.77 CYP2B6 (0.63) CYP2B6TSHRCYP2D6KCNH2CHRM2
SCHEMBL2491599 0.77 CYP2B6 (0.63) CYP2B6TSHRCYP2D6KCNH2CHRM2
SCHEMBL11201375 0.76 CYP2B6 (0.52) CYP2B6ALDH1A1TSHRCYP2D6KCNH2
SCHEMBL11201380 0.76 CYP2B6 (0.52) CYP2B6TSHRCYP2D6KCNH2CHRM2
SCHEMBL11201378 0.76 CYP2B6 (0.52) CYP2B6TSHRCYP2D6KCNH2CHRM2
SCHEMBL17810248 0.76 CYP2B6 (0.67) CYP2B6CYP2D6KCNH2CHRM2CHRM1
SCHEMBL2392136 0.75 CYP2B6 (0.59) CYP2B6ALDH1A1TSHRCYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678334-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2014-01-01 EP disclosed
EP-2627651-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-08-21 EP disclosed
WO-2012116257-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. (US) 2012-08-30 WO disclosed
WO-2012051361-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-04-19 WO disclosed